Cargando…

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia

Detalles Bibliográficos
Autor principal:	Rego, Eduardo Magalhães
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415747/ https://www.ncbi.nlm.nih.gov/pubmed/23049290 http://dx.doi.org/10.5581/1516-8484.20110048

Ejemplares similares

The expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Alegretti, Ana Paula, et al.
Publicado: (2011)

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2020)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy
por: Giunta, Marina, et al.
Publicado: (2012)

Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia
por: Sun, Yanni, et al.
Publicado: (2021)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia
por: Barr, Ronald Duncan
Publicado: (2011)

Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
por: Liang, Tianqi, et al.
Publicado: (2022)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications
por: Scrideli, Carlos Alberto
Publicado: (2012)

CD56(dim)CD16(dim) Natural Killer (NK) Cells: The Forgotten Population
por: Zimmer, Jacques
Publicado: (2020)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

Impact on patient of the detection of weakly expressed RhD antigens in blood donors()
por: Moraes-Souza, Helio, et al.
Publicado: (2015)

The treatment of acute lymphoblastic leukemia has come a long way but the best is yet to come
por: Chauffaille, Maria de Lourdes Lopes Ferrari
Publicado: (2013)

Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
por: Haltalli, Myriam L. R., et al.
Publicado: (2020)

Secondary myeloid neoplasias: an emerging group of diseases
por: Hernández-Rivas, Jesús M
Publicado: (2011)

Metaphase cytogenetics and single nucleotide polymorphism arrays in myeloid malignancies()
por: da Silva, Fernanda Borges, et al.
Publicado: (2015)

Kidd system antigens and kidney disease()
por: Barros, Melca Maria Oliveira
Publicado: (2017)

Qualitative polymerase chain reaction versus quantitative polymerase chain reaction for the detection of minimal residual disease in children with acute lymphoblastic leukemia()
por: Scrideli, Carlos Alberto, et al.
Publicado: (2015)

Scientific comment on: “Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms”()
por: Ikoma, Maura Rosane Valerio
Publicado: (2017)

A future without human leukocyte antigens?()
por: Gilli, Simone Cristina Olenscki
Publicado: (2018)

Human platelet antigens and primary immune thrombocytopenia()
por: Castro, Vagner
Publicado: (2017)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

Poor Prognosis in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
por: Xu, Junqing, et al.
Publicado: (2017)

Upregulation of Tim‐3 is associated with poor prognosis in acute myeloid leukemia
por: Wu, Zhengwei, et al.
Publicado: (2022)

Myeloid Sarcoma Presenting as Brain Tumor in Pediatric Acute Myeloid Leukemia Case
por: Solgun, Hüseyin Avni, et al.
Publicado: (2023)

Comments on: “Frequency of alleles and haplotypes of the human leukocyte antigen in Bauru, São Paulo”
por: de Souza, Vânia Nieto Brito
Publicado: (2014)

Comments on: frequency of alleles and haplotypes of the human leukocyte antigen system in Bauru, São Paulo
por: Silva, Sônia Maria Usó Ruiz
Publicado: (2014)

Red cell and human leukocyte antigen alloimmunization in candidates for renal transplantation: a reality
por: Mota, Mariza Aparecida
Publicado: (2013)

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia
por: Mu, Dan, et al.
Publicado: (2021)

High expression of B4GALT1 is associated with poor prognosis in acute myeloid leukemia
por: Ren, Zhihong, et al.
Publicado: (2022)

Oxidative status in sickle cell anemia
por: Magalhães, Silvia Maria Meira
Publicado: (2011)

Comments on: Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: de Paula, Erich Vinicius
Publicado: (2012)

PB1811: BIOLOGIC AND CLINICAL SIGNIFICANCE OF CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA: A POOR PROGNOSIS MARKER
por: Charfi, H., et al.
Publicado: (2022)

Comment on Association of FLT3-internal duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
por: Tong, Wing H., et al.
Publicado: (2022)

Special features of quantification of CD8(+)CD38(+) T-cells by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
por: Martins Filho, Olindo Assis
Publicado: (2011)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i1llpbmaelak77brsq8gt3uck3